Heat Biologics, Inc. Appoints Jeff Hutchins as Chief Scientific Officer and Senior Vice President of Preclinical Development
January 04, 2017 at 08:00 am EST
Heat Biologics, Inc. announced the appointment of Jeff Hutchins, Ph.D., as Chief Scientific Officer and Senior Vice President of Preclinical Development. Dr. Hutchins will be overseeing Heat’s research efforts, bringing over 24 years of research and clinical development experience from both large pharmaceutical and biotechnology companies. Most recently, Dr. Hutchins served as Vice President of Preclinical Research for Peregrine Pharmaceuticals, Inc.